Drimva

GSK

Global Market Access Senior Director, Oncology

USA - Pennsylvania - Upper Providence +1 · Hybrid (Remote & On-site) · Director · Full-time · Posted Sep 4, 2026

Location
USA - Pennsylvania - Upper Providence
UK – London – New Oxford Street
Experience
15+ years relevant experience; 5+ years in an above-country/global Oncology market access role; 5+ years in the US payer or access environment; 3+ years of people management experience.
Education
Advanced degree in Business, Medicine, Pharmacy, Health Economics, Health Policy or Science.

About the job

Leads the global oncology market access and pricing strategy, guiding teams and cross-functional partners to develop payer value propositions, evidence plans, and reimbursement support for portfolio products.

What you'll do

  • Lead a team advising the global oncology portfolio on market access and pricing strategies for pipeline and launch assets.
  • Coordinate cross-functional evidence planning and payer value proposition development, aligning evidence needs with asset strategies.
  • Support country affiliates with reimbursement negotiations through market-specific strategy, value dossiers, training, and workshops.

What they ask for

  • Advanced degree in Business, Medicine, Pharmacy, Health Economics, Health Policy, or Science.
  • 15+ years of relevant experience in a multinational context at pharmaceutical companies, payer or health technology assessment agencies, physician associations, or relevant consultancies.
  • 5+ years in an above-country or global oncology market access role and 5+ years in the US payer or access environment.
  • 3+ years of people management experience, including managing and developing teams or direct reports.

Nice to have

  • Experience shaping oncology payer value propositions, evidence plans, and global pricing and access strategies across hematology and solid tumor assets from early development through launch and lifecycle management.
  • Strategic judgment, communication, cross-functional leadership, relationship-building, and appreciation of external relations and public health issues in oncology.

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 6, 2026 (UTC)